富血小板血浆与利多卡因行针刀肌腱切开术治疗肘部肌腱病:二十个月临床与超声结局
本研究为患者与评估者盲法、优效性、利多卡因对照随机试验的前瞻性子研究,在三级医院对肘部肌腱病患者行两次间隔2周的针刀肌腱切开术,分别以富血小板血浆或利多卡因(4 ml)为辅助剂。20个月随访显示肌腱结构、厚度(±=0.0006)、血管性(p<0.0001)和回声纹理(p<0.0001)均发生改变,DASH-E和VAS-P分别有80.85%和90.91%患者达到有意义的临床改善且两组间无差异;两组血管性随时间变化有显著差异(未调整模型p=0.037,调整模型p=0.049),疼痛或功能与超声表现在各时间点均无关系。
要点
- 两次针刀肌腱切开术可改变顽固性肘部肌腱病的肌腱结构、厚度、血管性和回声纹理。
- 富血小板血浆组较利多卡因组随时间显示更多血管化和厚度增加,但功能或疼痛未改善。
- 疼痛或功能与超声表现各时间点均无关系。
核心结论
- 两次连续针刀肌腱切开术诱导顽固性肘部肌腱病结构改变,富血小板血浆较利多卡因随时间显示更多血管化和厚度增加,但20个月内未改善功能或减轻疼痛。
研究设计与样本
- 前瞻性子研究,患者与评估者盲法、优效性、利多卡因对照随机试验,在三级医院进行,两次针刀肌腱切开术间隔2周,辅助剂为富血小板血浆或利多卡因4 ml,基线及治疗后3、6、12、20个月评估。
关键影像表现/征象
- 肌腱厚度变化±=0.0006。
- 血管性变化p<0.0001。
- 回声纹理变化p<0.0001。
- 两组血管性随时间变化有显著差异,未调整模型p=0.037,调整模型p=0.049。
- 富血小板血浆组较利多卡因组随时间显示更多血管化和厚度增加。
诊断标准与关键数值
- DASH-E评分80.85%患者达到有意义的临床改善。
- VAS-P评分90.91%患者达到有意义的临床改善。
- 两组临床改善无差异。
- 疼痛或功能与超声表现各时间点均无关系。
临床应用与阅片要点
- 针刀肌腱切开术可诱导肘部肌腱病结构改变,超声随访可见厚度、血管性和回声纹理变化。
- 富血小板血浆组较利多卡因组显示更多血管化和厚度增加,但未转化为功能或疼痛改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate whether pathological changes in elbow epicondylopathy, as assessed by conventional ultrasonography and clinical outcomes, could be modified following tenotomy with platelet-rich plasma (PRP) versus tenotomy with lidocaine.
METHODS: This prospective sub-study was part of a patient- and assessor-blinded, superiority-type, randomized, lidocaine-controlled trial that was performed in a tertiary hospital to assess the effectiveness of PRP versus lidocaine as tenotomy adjuvants in patients with epicondylopathy. Patients were followed after two sessions of tenotomy with either PRP or lidocaine adjuvants (4 ml) within a 2-week interval. Tendon thickness, echotexture, and neovascularization were assessed as secondary outcome measurements at baseline and at 3, 6, 12, and 20 months after treatment, and correlations with clinical outcomes were examined.
RESULTS: Twenty months after treatment, tenotomy induced changes in tendon structure, thickness (± = 0.0006), vascularity (p < 0.0001), and echotexture (p < 0.0001). In Disabilities of the Arm, Shoulder and Hand (DASH-E) and pain (VAS-P) scores, 80.85% and 90.91% of patients showed a meaningful clinical improvement, respectively, without differences between PRP and lidocaine. There were significant differences in between-group changes in vascularity over time, p = 0.037 and p = 0.049 in the unadjusted and adjusted models, respectively. There was no relationship between pain or function and sonographic entities at the various time points.
CONCLUSIONS: Two successive needle tenotomies induced structural changes in recalcitrant epicondylopathy, with PRP displaying more vascularization and increased thickness over time compared to lidocaine. PRP compared with lidocaine did not result in improved function or decreased pain over 20 months.
引用
- Martin JI, Atilano L, Bully P, et al. Needle tenotomy with PRP versus lidocaine in epicondylopathy: clinical and ultrasonographic outcomes over twenty months. Skeletal Radiol. 2019. PMID: 30826853. doi:10.1007/s00256-019-03193-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。